Fujitsu Japan and JMDC Expand Digital Healthcare with Advanced Data Analytics and AI

This collaboration will see the two companies combine Fujitsu Japan's knowledge in the medical field and advanced technologies, including AI

Fujitsu Japan Limited and JMDC announced the commencement of a collaboration aimed at advancing medical care and contributing to the establishment of a sustainable healthcare system in Japan.

This collaboration, which began on January 5, leverages JMDC's expertise in utilising anonymised medical data and Fujitsu Japan's customer base. Fujitsu Japan holds the top share in the Japanese electronic health record (EHR) market for medical institutions. This synergy will accelerate the utilisation of medical data by medical institutions and organisations that are part of the healthcare system, while also supporting data-driven management decision-making.

This collaboration will see the two companies combine Fujitsu Japan's knowledge in the medical field and advanced technologies, including AI, with JMDC's prediction models based on insurance user data and its expertise cultivated through Pep Up, one of Japan's largest personal health record services used by 7.7 million people. This will expand the scope of data utilisation from DPC data to comprehensive EHR data. This initiative will further promote the utilisation of medical data, contributing to improved management for medical institutions and advanced research for pharmaceutical companies, government agencies, and academia.

In the future, Fujitsu Japan will contribute to the realisation of digital hospitals that promote DX in medical institutions. At the same time, JMDC will advance initiatives that contribute to "building a sustainable healthcare system through addressing social issues with the power of data and ICT" and "accelerating the societal integration of data."

Fujitsu Japan will provide Dashboard 360, a solution that enables visualisation and analysis of management and clinical data, free of charge to medical institutions that agree to provide anonymised DPC data. Dashboard 360 is offered as part of Fujitsu Limited's Uvance business model, which addresses societal challenges, specifically within the Smart Hospital offering that maximises hospital operational efficiency and effectiveness. It is a component of the Healthcare Management Platform, a suite of services designed to optimise patient flow in acute care hospitals and support the resolution of management challenges.

Dashboard 360 seamlessly integrates with EHRs, allowing for factor analysis of issues such as declining bed occupancy rates and waiting times for hospitalisation or surgery, based on information including inpatient care and outpatient conditions leading to hospitalisation. It also features a benchmarking function, utilising data provided by JMDC and DPC data from medical institutions, to support timely decision-making in hospital management.

JMDC will collaborate with Fujitsu Japan to anonymise DPC data in a secure environment and provide it to pharmaceutical companies, government agencies, and universities for research purposes. Additionally, by combining this with JMDC's accumulated insurance user data, covering approximately 20 million individuals, the collaboration will visualise the entire patient journey from pre-onset abnormal test results to inpatient treatment and post-discharge prognosis. This will enable early detection of diseases through screening of potential patients, prevention of severe cases by identifying risk factors, and precise evaluation of long-term treatment effects and drug safety in real-world settings, thereby contributing to the improvement of medical quality and efficiency.